HomeAbout UsPortfolioNewsContact Us

  • POWER THE COURSE OF FIGHTING DISEASES AND SAVING LIVES

    Domain expertise, global resource, long-term capital

  • PORTFOLIO NEWS

    Belief BioMed and Takeda China jointly announced BBM-H901 (Dalnacogene Ponparvovec Injection), China’s first hemophilia B gene therapy, was officially approved
    2025年4月11日
    Shanghai, China, April 10, 2025 – Belief BioMed ("BBM") and Takeda China today jointly announced...
    Syneron Bio Announces Strategic Collaboration with AstraZeneca
    2025年3月21日
    BEIJING, March 21, 2025 /PRNewswire/ -- Syneron Bio, a cutting-edge oral macrocyclic peptide drug...
    Senaparib Approved by NMPA for 1L Maintenance Therapy in Ovarian Cancer
    2025年1月17日
    SHANGHAI, January 16th, 2025 - IMPACT Therapeutics ("IMPACT"), a biopharmaceutical company...
    More Posts
    Cookie Use
    We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
    Learn More